QUOIN PHARMACEUTICALS LTD's ticker is and the CUSIP is 74907L102. A total of 7 filers reported holding QUOIN PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $198,000 | – | 108,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 64,932 | $29,000 | 0.00% |
| UBS Group AG | 9,674 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 14,392 | $6,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 22,000 | $256,000 | 0.00% |
| CITIGROUP INC | 13,000 | $6,000 | 0.00% |
| Citadel Advisors | 19,582 | $9,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 16,108 | $7,000 | 0.00% |
| HRT FINANCIAL LP | 10,229 | $4,000 | 0.00% |